Overview

Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and pharmacokinetics following a single oral dose of MBX-400.
Phase:
Phase 1
Details
Lead Sponsor:
Microbiotix, Inc.